Targeted protein degradation using the lysosomal pathway.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• PROteolysis TArgeting Chimeras (PROTACs) leverage the ubiquitin-proteasomal pathway for targeted protein degradation.
• Conventional PROTACs are effective but cannot address all target classes, such as large proteins or aggregates.
• The ubiquitin-proteasomal system has limitations in degrading certain cellular components.

Purpose of the Study:

• To review targeted degradation strategies that utilize the lysosomal pathway.
• To explore the potential of lysosomal degradation as an alternative to the ubiquitin-proteasomal system.
• To highlight novel approaches for targeting previously undruggable macromolecules.

Main Methods:

• Literature review of targeted degradation strategies.
• Analysis of mechanisms involving the lysosomal degradation pathway.
• Comparison of lysosomal and ubiquitin-proteasomal degradation systems.

Main Results:

• The lysosomal pathway offers a viable alternative for targeted degradation.
• Lysosomal targeting can address macromolecular targets resistant to proteasomal degradation.
• Emerging PROTACs and related molecules are being developed to harness lysosomal degradation.

Conclusions:

• Lysosomal degradation represents a significant advancement in targeted degradation therapies.
• This approach expands the scope of druggable targets for various diseases.
• Further research into lysosomal targeting modalities holds therapeutic promise.